Association between poly-sensitisation and sensitisation to staphylococcal enterotoxin A and B affecting allergic severity in children
- PMID: 37039894
- DOI: 10.1007/s00405-023-07968-0
Association between poly-sensitisation and sensitisation to staphylococcal enterotoxin A and B affecting allergic severity in children
Abstract
Purpose: Accumulating evidence suggests that Staphylococcus aureus plays a significant role as a disease modifier in upper and lower airway diseases. We aimed to assess the association between staphylococcal enterotoxins (SEs) with allergic diseases and the degree of allergen sensitisation in children, which remains unclear.
Methods: We retrospectively reviewed the medical records of 455 patients aged 3-18 years between March 2018 and March 2022. Clinical history and demographic data were obtained. The baseline study included paranasal sinus X-ray scan, multiple allergen simultaneous test, and ImmunoCAP® for measuring serum total and specific immunoglobulin E (IgE) levels to allergens and staphylococcal enterotoxin A and B (SEA and SEB).
Results: The mean age was 9.77 ± 4.3 years. 133 patients (29.2%) were sensitised to one inhalant allergen, and 188 patients (41.3%) showed polysensitisation. Patients sensitised to SEs showed higher total and specific IgE levels and total eosinophil counts compared to non-SE-sensitised patients. Sensitisation to SEs is closely associated with polysensitisation to inhalant allergens and allergic multimorbidity. When the SE-IgE value was 0.35 or higher, the odds ratio for allergen polysensitisation was significantly higher than when the SE-IgE value was lower than 0.35.
Conclusions: Association between polysensitisation and sensitisation to SEs in children shows the higher the specific IgE levels for SEs, the higher the likelihood of polysensitisation. Considering the relationship between polysensitisation, high IgE levels, and the severity of allergic morbidity, sensitisation to SEs is thought to be related to allergy severity.
Keywords: Allergy; Children; Enterotoxin; Severity; Staphylococcus.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Wertheim HF (2009) Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 199:1820–1826. https://doi.org/10.1086/599119 - DOI - PubMed
-
- Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5:751–762. https://doi.org/10.1016/S1473-3099(05)70295-4 - DOI - PubMed
-
- Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28:603–661. https://doi.org/10.1128/CMR.00134-14 - DOI - PubMed - PMC
-
- Teufelberger AR, Broker BM, Krysko DV, Bachert C, Krysko O (2019) Staphylococcus aureus orchestrates type 2 airway diseases. Trends Mol Med 25:696–707. https://doi.org/10.1016/j.molmed.2019.05.003 - DOI - PubMed
-
- Muluk NB, Altin F, Cingi C (2018) Role of superantigens in allergic inflammation: their relationship to allergic rhinitis, chronic rhinosinusitis, asthma, and atopic dermatitis. Am J Rhinol Allergy 32:502–517. https://doi.org/10.1177/1945892418801083 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
